Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Flora Growth Corp. FLGC NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$173.50
+2127.2%

Flora Growth Corp. (FLGC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $7.79. It has a SharesGrow Score of 47/100, indicating a mixed investment profile with 3 out of 7 criteria passed.

Analyst consensus target is FLGC = $174 (+2127.2% upside).

Financials: revenue is $14M, +2.4%/yr average growth. Net income is $4M (loss), growing at +45.3%/yr. Net profit margin is -30.5% (negative). Gross margin is 43.3% (+4.5 pp trend).

Balance sheet: total debt is $54M against $71M equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 1.01 (adequate). Debt-to-assets is 41.4%. Total assets: $130M.

Analyst outlook: 4 / 6 analysts rate FLGC as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 73/100 (Pass), Past 0/100 (Fail), Health 33/100 (Fail), Moat 43/100 (Fail), Future 73/100 (Pass), Income 10/100 (Fail).

$173.50
▲ 2127.21% Upside
Average Price Target
Based on 6 Wall Street analysts offering 12-month price targets for Flora Growth Corp., the average price target is $173.50, with a high forecast of $340.00, and a low forecast of $7.00.
Highest Price Target
$340.00
Average Price Target
$173.50
Lowest Price Target
$7.00

FLGC SharesGrow Score Overview

55/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 73/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 43/100
Gross margin is + market cap
FUTURE 73/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — FLGC

✓
VALUE Pass
100/100
FLGC trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $174, implying +2133.6% from the current price $8. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✓
GROWTH Pass
73/100
FLGC: +2.4%/yr revenue is, +45.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet FLGC: Debt-to-Equity (D/E) ratio 0.76 (moderate), Current ratio is 1.01 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
43/100
FLGC: Gross margin is 43.3% (+4.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 43/100. ≥ 70 = Pass.
View details →
✓
FUTURE Pass
73/100
Analyst outlook: 4 / 6 analysts rate FLGC as buy (67%). Analyst consensus target is $174 (+2133.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
FLGC: Net profit margin is -30.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range5.86-47
Volume107.94K
Avg Volume (30D)96.65K
Market Cap$4.23M
Beta (1Y)1.90
Share Statistics
IPO Date2021-05-11
Employees64
CEODaniel Reis-Faria
Financial Highlights & Ratios
Revenue (TTM)$14.5M
Gross Profit$6.29M
EBITDA$-3.82M
Net Income$-4.43M
Operating Income$-4.46M
Total Cash$5.6M
Total Debt$53.93M
Net Debt$48.34M
Total Assets$130.24M
Price / Sales (P/S)0.29
Analyst Forecast
1Y Price Target$173.50
Target High$340.00
Target Low$7.00
Upside+2,127.2%
Rating ConsensusBuy
Analysts Covering6
Buy 67% Hold 33% Sell 0%
Price Target Summary
Company Info
CountryCA
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINCA3397643006

Price Chart

Track all markets on TradingView
FLGC
Flora Growth Corp. ↗  ·  NASDAQ Capital Marke
Healthcare • Drug Manufacturers - Specialty & Generic
5.86 52WK RANGE 47.00

People Also View

APNHF
APNHF
Aspen Pharmacare Holdings Limited
$8.69
+0.00%
 TKNO
TKNO
Alpha Teknova, Inc.
$2.74
-9.57%
 INCR
INCR
InterCure Ltd.
$0.75
-1.49%
 MEDIF
MEDIF
MediPharm Labs Corp.
$0.05
+0.28%
 PCLOF
PCLOF
PharmaCielo Ltd.
$0.04
+0.72%
 BCBCF
BCBCF
The BC Bud Corporation
$0.04
-3.31%
 BBRRF
BBRRF
Blueberries Medical Corp.
$0.01
-16.00%
 SBFM
SBFM
Sunshine Biopharma, Inc.
$1.00
+3.22%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message